Epstein-Barr virus genome in infected cells and cancer

Gann Monographs on Cancer Research

Volumn 45, Issue , 1998, Pages 29-39

  Hirai, Kanji ^a   Yamamoto, Takako ^a,c   Hironaka, Takashi ^a   Arai, Takashi ^b   Takeuchi, Hiroaki ^a   Kobayashi, Ryo ^a,d   Hojo, Isao ^a   Oishi, Tsutomu ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^c SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^d JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN 1; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; CONTROLLED STUDY; DNA DNA HYBRIDIZATION; EPSTEIN BARR VIRUS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; T CELL LYMPHOMA; VIRUS CARCINOGENESIS; VIRUS GENE; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0031978864     PISSN: 00720151     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (46)

1. Azuma, H., Sakata, Y., Sasaki, K. et al. Hodgkin's disease developed in a patient with extremely high serum antibody titers against Epstein-Barr virus associated antigens without chronic illness. J Pediatr. Hematol./Oncol., 18, 387-391 (1996).
2. Decker, L., Klaman, L. D., and Thorley-Lawson, D. A. Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals. J. Virol., 70, 3286-3289 (1996).
3. Delecluse, E.-H., Bartnike, S., Hammerschmidt, W., Bullerdiek, J., and Bornkamm, G. W. Episomal and integrated copies of Epstein-Barr virus coexist in Burkitt lymphoma cell lines. J. Virol., 67, 1292-1299 (1993).
4. Fukayama, M., Hayashi, Y., Iwasaki, Y. et al. Epstein-Barr virus associated gastric carcinoma and EBV-infection of the stomach. Lab. Invest., 71, 73-81 (1994).
5. Gilligan, K., Rajadurai, P., Resnick, L., and Raab-Traub, N. Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc. Natl. Acad. Sci. USA, 87, 8790-8794 (1990).
6. Gualandi, G., Santolini, E., and Calef, E. Epstein-Barr virus DNA recombines via latent origin of replication with the human genome in the lymphoblastoid cell line RGN1. J. Virol., 66, 5677-5681 (1992).
7. Gulley, M. L., Raphael, M., Lutz, C. T., Ross, D. W., and Raab-Traub, N. Epstein-Barr virus integration in human lymphomas and lymphoid cell lines. Cancer, 70, 185-191 (1992).
8. Harris, A., Young, B. D., and Griffin, B. E. Random association of Epstein-Barr virus genomes with host cell metaphase chromosomes in Burkitt's lymphoma-derived cell lines. J. Virol., 56, 328-332 (1985).
9. Henderson, A., Ripley, S., Heller, M., and Kieff, E. Chromosome site for Epstein-Barr virus in a Burkitt tumor cell line and in lymphocytes growth-transformed in vitro. Proc. Natl. Acad. Sci. USA, 80, 1987-1991 (1983).
10. Henderson, S., Rowe, M., Gregory, C. et al. Induction of bcl-2 expression by Epstein-Barr virus membrane protein 1 protects infected B cells from programmed cell death. Cell, 65, 1107-1115 (1991).
11. Hirai, K., Hironaka, T., and Yamamoto, T. Structure and expression of standard Epstein-Barr virus DNA in a P3HR-1 subclone containing a single viral genome equivalent per cell. In "The Epstein-Barr Virus and Associated Diseases," ed. T. Tursz et al., Colloque INSERM vol. 225, pp. 289-294 (1993). John Libbey Eurotext, Ltd., Montrouqe, France.
12. Hironaka, T., Nagasaki, M., Morikawa, S., and Hirai, K. Detection of Epstein-Barr virus transcripts in chemically or immunologically-activated cells and in a null cell-line (HLN-STL-C) by in situ hybridization with alkaline phosphatase-linked oligonucleotide probes. J. Virol. Methods, 44, 141-154 (1993).
13. Hojo, I., Takanashi, M., Hirai, K., and Mori, S. Increased number of Epstein-Barr virus latently infected B-cells in T-cell non-Hodgkin's lymphoma tissues. Arch. Virol., 140, 1419-1426 (1995).
14. Hurley, E., Klaman, L. D., Agger, S., Lawrence, J. B., and Thorley-Lawson, D. A. The prototypical Epstein-Barr virus-transformed lymphoblastoid cell line IB4 is an unusual variant containing integrated but no episomal viral DNA. J. Virol., 65, 3958-3963 (1991).
15. Ishihara, S., Tawa, A., Yumura-Yagi, K. et al. Clonal T-cell lymphoproliferation containing Epstein-Barr (EB) virus DNA in a patient with chronic active EB virus infection. Jpn. J. Cancer Res., 80, 99-101 (1989).
16. Itoh, T., Shiota, M., Takanashi, M. et al. Engraftment of human lymphomas in mice with severe combined immunodeficiency (SCID). Cancer, 72, 2686-2694 (1993).
17. Kawa-Ha, K., Ishihara, S., Ninomiya, T. et al. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J. Clin. Invest., 84, 51-55 (1989).
18. Kikuta, H., Taguchi, Y., Tomizawa, K. et al. Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature, 333, 455-457 (1988).
19. Kikuta, H., Sakiyama, Y., Matsumoto, S. et al. Fatal Epstein-Barr virus-associated hemophagocytic syndrome. Blood, 82, 3259-3264 (1994).
20. Klipalani-Joshi, S. and Law, H. Y. Identification of integrated Epstein-Barr virus in nasopharyngeal carcinoma using pulse field gel electrophoresis. Int. J. Cancer, 56, 187-192 (1994).
21. Korbjun, P., Anagnostopoulos, I., Hummel, M. et al. Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B cells in human immunodeficiency virus-negative European peripheral pleomorphic T-cell lymphomas. Blood, 82, 217-223 (1993).
22. Koyanagi, Y., Yamamoto, Y., Kobayashi, N. et al. Characterization of human B-cell lines harbouring both adult T-cell leukemia (ATL) virus and Epstein-Barr virus derived from ATL patients. J. Gen. Virol., 65, 1781-1789 (1984).
23. Laux, G., Perricaudet, M., and Farrel, P. J. A spliced Epstein-Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genome. EMBO J., 7, 769-775 (1988).
24. Lawrence, J. B., Villnave, C. A., and Singer, R. H. Sensitive, high-resolution chromatin and chromosome mapping in situ: presence and orientation of two closely integrated copies of EBV in a lymphoma line. Cell, 52, 51-61 (1988).
25. Manolov, G. and Manolov, Y. Marker band in one chromosome 14 from Burkitt lymphomas. Nature, 237, 33-34 (1972).
26. Matsuo, T., Heller, M., Petti, L., Oshiro, E., and Kieff, E. Persistence of the entire EBV genome integrated into human lymphocyte DNA. Science, 226, 1322-1325 (1984).
27. Miyashita, E. M., Yang, B., Lam, K. M. C., Crawford, D. C., and Thorley-Lawson, D. A. A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell, 80, 593-601 (1995).
28. Mosier, D. E., Baired, S. M., Kirven, M. B. et al. EBV-associated B cell lymphomas following transfer of human peripheral blood lymphocytes to mice with severe combined immune deficiency. Curr. Top. Microbiol. Immunol., 166, 317-323 (1990).
29. Muso, E., Fujiwara, H., Yoshida, H. et al. Epstein-Barr virus genome-positive tubulo- interstitial nephritis with Kawasaki disease-like coronary aneurysms. Clin. Nephrol., 40, 7-15 (1993).
30. Nagasaki, M., Harada, T., Torii, I. et al. An autopsy case of acquired immune deficiency syndrome (AIDS) with preceding aplastic anemia. Pathol. Int., 44, 850-856 (1994).
31. Popescu, N. C., Chen, M. C., Simpson, S., Solinas, S., and Dipaolo, J. A. A Burkitt lymphoma cell line with integrated Epstein-Barr virus at a stable chromosome modification site. Virology, 195, 248-251 (1993).
32. Qu, L. and Rowe, D. T. Epstein-Barr latent gene expression in uncultured peripheral blood lymphocytes. J. Virol., 66, 3715-3724 (1992).
33. Raab-Traub, N. and Flynn, K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell, 47, 883-889 (1986).
34. Rickinson, A. B. and Kieff, E. Epstein-Barr virus. In "Fields Virology," ed. B. N. Fields, D. M. Knipe, and P. M. Howley, vol. 2, pp. 2397-2446 (1996). Lippincott-Raven Publishers, Philadelphia.
35. Sasajima, Y., Yamabe, H., Kobayashi, Y., Hirai, K., and Mori, S. High expression of the Epstein-Barr virus latent protein EBNA2 in pyothorax-associated lymphomas (PALs). Am. J. Pathol., 143, 1280-1285 (1993).
36. Shimakage, M., Chatani, M., Ikegami, N., and Hirai, K. Rearranged Epstein-Barr virus genomes and clonal origin in nasopharyngeal carcinoma. Jpn. J. Cancer. Res., 80, 612-616 (1989).
37. Shimojo, N., Hatano, M., Hoshikawa, A. et al. Chronic EB infection terminated in malignant lymphoma: a case report.Jpn. J. Clin. Hematol., 29, 851-854 (1988).
38. Shiraishi, Y., Taguchi, T., Ohta, Y., and Hirai, K. Chromosomal localization of the Epstein-Barr virus (EBV) genome in Bloom's syndrome B-lymphoblastoid cell lines transformed with EBV. Chromosoma, 93, 157-164 (1985).
39. Suzushima, H., Matsushita, S., Nakamura, R. et al. Detection of Epstein-Barr viral DNA in aggressive CDS+ T cell leukemic cells. Br. J. Haematol., 82, 774-776 (1992).
40. Takeuchi, H., Kobayashi, R., Hasegawa, M., and Hirai, K. Highly sensitive detection of latent infection by Epstein-Barr virus in peripheral blood cells of healthy individuals and in non-neoplastic tonsillar tissues from tonsillitis patients by reverse transcription-polymerase chain reaction. J. Virol. Methods, 58, 81-89 (1996).
41. Tanaka, A., Nonoyama, M., and Hampar, B. Partial elimination of latent Epstein-Barr virus genomes from virus-producing cells by cyclohexamide. Virology, 70, 164-170 (1976).
42. Tierney, R. T., Steven, N., Young, L. S., and Rickinson, A. B. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J. Virol., 68, 7374-7385 (1994).
43. Wolf, J., Pawlita, M., Jox, A. et al. Integration of Epstein-Barr virus near the breakpoint of a translocation 11;19 in a Burkitt's lymphoma cell line. Cancer Genet. Cytogenet., 67, 90-94 (1983).
44. Yamamoto, M., Kimura, H., Hironaka, T. et al. Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus associated diseases. J. Clin. Microb., 33, 1765-1768 (1995).
45. Yamamoto, T., Nakajima, Y., Yamamoto, M., Hironaka, T., Hirai, K., and Nakamura, Y. Epstein-Barr virus (EBV) activity in patients on chronic hemodialysis. Nephron, 70, 449-454 (1995).
46. Yandava, C. N. and Speck, S. H. Characterization of the deletion and rearrangement in the BamHI C region of the X50-7 Epstein-Barr virus genome, a mutant viral strain which exhibits constitutive BamHI W promoter activity. J. Virol., 66, 5646-5650 (1992).